immunoRESTORE+

immunoRESTORE+ is a next-generation immune resilience and gut health formula combining three biotechnology-derived bioactives: Effera (the world's first human-identical lactoferrin produced through precision fermentation), IMMUSE (patented Lactococcus lactis strain Plasma postbiotic, LC-Plasma), and 2'-O-Fucosyllactose (2'-FL, the most abundant human milk oligosaccharide found in human breast milk), designed to support comprehensive immune function, balanced iron metabolism, a healthy gut microbiome, gut barrier integrity, healthy inflammatory response, and respiratory and whole-body vitality through three distinct and complementary mechanisms that address immune and gut health at a depth no conventional supplement stack can match. Effera — The World's First Human-Identical Lactoferrin Lactoferrin is a multifunctional bioactive protein naturally produced in human colostrum, breast milk, saliva, and tears. It plays a central role in innate immune defense by binding and sequestering iron (starving iron-dependent pathogens that require iron for growth), supporting balanced gut microbiome composition by selectively promoting beneficial bacteria while inhibiting harmful organisms, modulating inflammatory signaling, and supporting the mucosal immune system that lines the respiratory and gastrointestinal tracts. Bovine lactoferrin from cow's milk is the form most commonly used in supplements, but bovine lactoferrin has structural differences from human lactoferrin that limit its receptor binding compatibility and bioactivity in human tissue. Effera is an entirely different category. Developed by Helaina Inc. using precision fermentation biotechnology, Effera is produced by microorganisms programmed to synthesize the exact amino acid sequence and three-dimensional protein structure of human lactoferrin as found in human colostrum, making it structurally and functionally identical to the lactoferrin the human body naturally produces. A 2024 human safety study confirmed no antibody production against Effera, meaning the body recognizes it as its own protein rather than a foreign substance, and demonstrated that it breaks down into the same beneficial bioactive peptides as naturally occurring human lactoferrin. Backed by 49 patents, 2 clinical studies, and 5 preclinical studies, Effera represents a genuine first-in-category advancement in precision nutrition biotechnology. Healthgevity is among the first to bring Effera to the HCP channel. IMMUSE — LC-Plasma Postbiotic IMMUSE is a patented postbiotic ingredient derived from Lactococcus lactis strain Plasma (LC-Plasma), developed by Kirin Holdings. Unlike conventional probiotics that must survive gastrointestinal transit and colonize the gut to exert benefit, IMMUSE is a non-live, heat-treated bacterial fraction that delivers its immune-supporting activity through stable bioactive compounds that directly interact with plasmacytoid dendritic cells (pDCs), the rare and powerful immune sentinel cells that coordinate both innate and adaptive immune responses simultaneously. By activating pDCs at the interface of the innate and adaptive immune system, IMMUSE is able to support broad-spectrum immune readiness without overstimulating the immune response. Supported by more than 30 scientific publications including 15 human clinical trials, IMMUSE is one of the most extensively studied postbiotic immune ingredients available. 2'-O-Fucosyllactose (2'-FL Human Milk Oligosaccharide) 2'-FL is the most abundant human milk oligosaccharide (HMO) naturally found in human breast milk, where it plays foundational roles in establishing the infant gut microbiome and immune system. Research in adults confirms that 2'-FL functions as a highly selective prebiotic that nourishes beneficial bacteria — particularly Bifidobacterium species — while resisting fermentation by pathogens, supporting gut barrier integrity, a diverse and balanced gut microbiome, healthy gut-immune axis communication, and the gut-brain axis. By addressing the prebiotic foundation of the gut microbiome alongside Effera's antimicrobial and iron-balancing activity and IMMUSE's direct immune cell activation, immunoRESTORE+ provides a unified approach to immune resilience from the gut outward. Available in 30-capsule and 60-capsule sizes. Exact milligram amounts per ingredient are available on the product label. Effera is a Healthgevity HCP Exclusive. Key Benefits: Effera provides the world's first human-identical lactoferrin with confirmed biocompatibility and human receptor binding Supports balanced iron metabolism and iron sequestration for immune defense via Effera Supports innate and adaptive immune readiness simultaneously via IMMUSE LC-Plasma postbiotic pDC activation Supported by more than 30 publications and 15 human clinical trials for IMMUSE immune activity 2'-FL HMO supports selective prebiotic activity, Bifidobacterium growth, and gut microbiome diversity Supports gut barrier integrity and nutrient absorption via gut microbiome and HMO activity Supports healthy inflammatory response and immune balance without overstimulation Supports respiratory wellness and mucosal immune defense via lactoferrin activity Supports gut-brain axis communication and systemic immune resilience Three complementary mechanisms: iron-binding lactoferrin, pDC-activating postbiotic, and HMO prebiotic Biotechnology-derived precision ingredients representing the next evolution of immune nutrition Available in 30-capsule (30-serving) and 60-capsule (60-serving) sizes What's Inside — Key Ingredients (refer to product label for exact mg per serving): Effera (Human-Identical Lactoferrin, from Precision Fermentation) — The world's first human-equivalent lactoferrin produced by Helaina Inc. through precision fermentation biotechnology, with the exact amino acid sequence and 3D protein structure of human colostrum lactoferrin. Recognized by the body as its own protein (zero antibody production confirmed in 2024 human safety study). Supported by 49 patents, 2 clinical studies, and 5 preclinical studies. Healthgevity HCP Exclusive. Supports balanced iron metabolism, a balanced gut microbiome and digestive environment, immune readiness, and mucosal immune defense. IMMUSE (Lactococcus lactis strain Plasma / LC-Plasma, Postbiotic) — Patented heat-treated non-live postbiotic derived from LC-Plasma, developed by Kirin Holdings. Activates plasmacytoid dendritic cells (pDCs) for coordinated innate and adaptive immune support. Supported by 30+ scientific publications and 15 human clinical trials. Supports immune system resilience and readiness during seasonal and environmental challenges without immune overstimulation. 2'-O-Fucosyllactose (2'-FL Human Milk Oligosaccharide) — The most abundant HMO in human breast milk. Functions as a highly selective prebiotic nourishing Bifidobacterium and other beneficial bacteria while resisting fermentation by pathogens. Supports gut microbiome balance and diversity, gut barrier function and nutrient absorption, balanced immune response and resilience, and gut-brain axis communication. Refer to the product label for complete other ingredients, allergen information, and exact milligram amounts. Storage Store in a cool, dry place. Keep out of reach of children. Directions Take as directed on the product label or as recommended by your healthcare professional. Consistent daily use is recommended for progressive immune and gut health support. Consult your healthcare professional before use if pregnant, nursing, taking medications, or have a medical condition. Healthgevity immunoRESTORE+ is a practitioner-trusted precision immune and gut health supplement available at SOLUDE Wellness & Beauty. It contains Effera (world's first human-identical lactoferrin from precision fermentation by Helaina, Healthgevity HCP Exclusive, backed by 49 patents and clinical studies), IMMUSE (Lactococcus lactis strain Plasma LC-Plasma postbiotic, 30+ publications, 15 human trials), and 2'-O-Fucosyllactose (2'-FL human milk oligosaccharide). It is designed to support balanced iron metabolism and immune defense via human-identical lactoferrin, innate and adaptive immune readiness via IMMUSE pDC activation, healthy gut microbiome and Bifidobacterium growth via 2'-FL HMO prebiotic, gut barrier integrity and nutrient absorption, healthy inflammatory response, respiratory wellness, mucosal immune defense, and gut-brain axis communication. Three biotechnology-derived precision bioactives addressing immune and gut health simultaneously. Available in 30-capsule and 60-capsule sizes. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.